impaired glucose tolerance, diabetes mellitus
Conditions
Sponsors
Shonan Keiiku Hospital
Keio University, Graduate School of Media and Governance
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. A patient whose fasting blood glucose level is over 110 mg/dL, or casual blood glucose level is over 125 mg/dL, or HbA1c is over 6.5% 2. A patient who attended nutritional guidance 4 weeks or more before starting this study
Exclusion criteria
Exclusion criteria: 1. A patient who is taking any drugs for diabetes mellitus other than DPP4 inhibitor 2. A patient who cannot stop any supplements health food affecting blood glucose level 3. A patient who is pregnant, or may become pregnant, or desire to get pregnant 4. A patient who has or had serious diseases in heart, liver, kidney, gastrointestinal tract, etc. 5. A patient who has allergy for any drugs or food 6. A patient who has or had drug or alcohol dependence 7. A patient who is judged to be unsuitable for this study by the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in blood glucose level or HbA1c in the patients whose blood glucose level is higher than normal range at 4 and 12 weeks after taking burdock sprout extract. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of body weight, liver function, serum lipid levels, insulin level, GLP-1, HOMA-IR, ghrelin level and adipokine levels such as leptin and adiponectine in the patients whose blood glucose level is higher than normal range at 4 and 12 weeks after taking burdock sprout extract. | — |
Countries
Japan
Contacts
Public ContactKenji Miyazaki
Shonan Keiiku Hospital Office
Outcome results
None listed